Hipercium species in the treatment of depression - a literature overview
Authors:
- Justyna DrożdżałJDJustyna Drożdżał
- Oliwia BarańskaOBOliwia Barańska
- Małgorzta ChańkoMCMałgorzta Chańko
- Adam KrzaczkowskiAKAdam Krzaczkowski
- Emilia NiedzielskaENEmilia Niedzielska
- Magadalena RędaszkaMRMagadalena Rędaszka
- Joanna SzubaJSJoanna Szuba
- Zofia SzularZSZofia Szular
- Tymon WojczulisTWTymon Wojczulis
- Katarzyna ZiemekKZKatarzyna Ziemek
Open Access
- 17 June 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 42, 60806
Abstract
Hypericum perforatum, commonly known as St. John’s wort, has gained considerable attention as a herbal alternative in the treatment of mild to moderate depression. Given its favorable safety profile, natural origin, and evidence-based efficacy, it may represent a valuable support tool in mental health care, including among physically active individuals. The plant’s therapeutic potential stems from the synergistic action of compounds such as hyperforin and hypericin, which modulate neurotransmitter systems and neuroinflammation. Clinical studies and meta-analyses confirm that H. perforatum demonstrates comparable effectiveness to conventional antidepressants, while showing fewer side effects. Although its interaction with other medications requires caution, the growing interest in phytotherapy highlights its relevance in supporting psychological well-being, especially in stress-prone populations, such as athletes or individuals seeking non-pharmacological interventions.Keywords
This publication has 29 references indexed in Scilit:
- Hypericum perforatum L. (St. John's Wort) in broilers diet improve growth performance, intestinal microflora and immunityPoultry Science, 2024
- Hyperibone J exerts antidepressant effects by targeting ADK to inhibit microglial P2X7R/TLR4-mediated neuroinflammationJournal of Advanced Research, 2024
- Characterization of pregnancies exposed to St. John’s wort and their outcomes: A claims data analysisReproductive Toxicology, 2021
- Medicinal Plants in the Treatment of Depression: Evidence from Preclinical StudiesPlanta Medica, 2021
- Herbal medicines and phytochemicals for obsessive–compulsive disorderPhytotherapy Research, 2020
- The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trialComplementary Therapies in Medicine, 2019
- Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of actionJournal of Cellular Physiology, 2018
- The water extract of tutsan (Hypericum androsaemum L.) red berries exerts antidepressive-like effects and in vivo antioxidant activity in a mouse model of post-stroke depressionBiomedicine & Pharmacotherapy, 2018
- Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditionsJournal of Ethnopharmacology, 2017
- Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysisProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2009